Mortality Risk Stratification in Heart Failure. The Search for the Holy Grail Continues! Autonomic Nervous System Analysis is Back!
作者信息
Rocha Eduardo Arrais, Cunha Bianca Lopes, Brasil Helena Nogueira, Pereira Francisca Tatiana Moreira, Pires Neto Roberto da Justa
机构信息
Faculdade de Medicina da Universidade Federal do Ceará, Fortaleza, CE - Brasil.
Centro de Arritmia do Ceará, Fortaleza, CE - Brasil.
出版信息
Arq Bras Cardiol. 2023 Feb;120(11):e20230761. doi: 10.36660/abc.20230761.
Abstract
摘要
相似文献
1
Mortality Risk Stratification in Heart Failure. The Search for the Holy Grail Continues! Autonomic Nervous System Analysis is Back!心力衰竭中的死亡风险分层。对圣杯的探寻仍在继续！自主神经系统分析回归了！
Arq Bras Cardiol. 2023 Feb;120(11):e20230761. doi: 10.36660/abc.20230761.
2
Heart Rate Turbulence Is a Powerful Predictor of Cardiac Death and Ventricular Arrhythmias in Postmyocardial Infarction and Heart Failure Patients: A Systematic Review and Meta-Analysis.心率震荡是心肌梗死后及心力衰竭患者心脏性死亡和室性心律失常的有力预测指标：一项系统评价和荟萃分析。
Circ Arrhythm Electrophysiol. 2016 Dec;9(12). doi: 10.1161/CIRCEP.116.004610.
3
A Simple Prognostic Index Based on Heart Rate, Age, and Systolic Blood Pressure for the Risk Stratification of Heart Failure With Preserved Ejection Fraction.
Heart Lung Circ. 2025 Sep;34(9):883-890. doi: 10.1016/j.hlc.2025.03.007. Epub 2025 Jun 30.
4
The Use of Metabolomes in Risk Stratification of Heart Failure Patients: Protocol for a Scoping Review.运用代谢组学对心力衰竭患者进行危险分层：系统评价方案。
JMIR Res Protoc. 2024 May 23;13:e53905. doi: 10.2196/53905.
5
Angiotensin Receptor-Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure.血管紧张素受体-脑啡肽酶抑制剂与心力衰竭患者心脏自主神经功能改善相关。
J Am Heart Assoc. 2024 Aug 6;13(15):e033538. doi: 10.1161/JAHA.123.033538. Epub 2024 Jul 31.
6
Association between ultra-short-term heart rate variability and atrial fibrillation in heart failure population: a protocol for a prospective observational cohort study.心力衰竭人群中超短期心率变异性与心房颤动之间的关联：一项前瞻性观察性队列研究方案
BMJ Open. 2025 Aug 1;15(7):e101170. doi: 10.1136/bmjopen-2025-101170.
7
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
8
Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy.用于治疗恰加斯心肌病患者心力衰竭的药物干预措施。
Cochrane Database Syst Rev. 2016 Jul 8;7(7):CD009077. doi: 10.1002/14651858.CD009077.pub3.
9
Heart Rate Variability's Value in Predicting Out-of-Hospital Major Adverse Cardiovascular Events in Patients With Chronic Heart Failure.心率变异性在预测慢性心力衰竭患者院外重大心血管不良事件中的价值
Cardiovasc Ther. 2025 Aug 14;2025:6412775. doi: 10.1155/cdr/6412775. eCollection 2025.
10
Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy.用于治疗恰加斯心肌病患者心力衰竭的药物干预措施。
Cochrane Database Syst Rev. 2012 Nov 14;11:CD009077. doi: 10.1002/14651858.CD009077.pub2.
引用本文的文献
1
Is it Fair to Contraindicate Cardiac Defibrillator Implantation for Patients with Socioeconomic or Psychological Vulnerability?对具有社会经济或心理脆弱性的患者禁忌植入心脏除颤器是否公平？
Arq Bras Cardiol. 2024 Dec 2;121(10):e20240643. doi: 10.36660/abc.20240643. eCollection 2024.
本文引用的文献
1
Predictive Model of All-Cause Death in Patients with Heart Failure using Heart Rate Variability.基于心率变异性的心力衰竭患者全因死亡预测模型。
Arq Bras Cardiol. 2023 Nov;120(11):e20220379. doi: 10.36660/abc.20220379.
2
[Not Available].[无可用内容]。
Arq Bras Cardiol. 2018 Sep;111(3):436-539. doi: 10.5935/abc.20180190.
3
Development and Validation of Predictive Models of Cardiac Mortality and Transplantation in Resynchronization Therapy.心脏再同步治疗中心脏死亡率和移植预测模型的开发与验证
Arq Bras Cardiol. 2015 Oct;105(4):399-409. doi: 10.5935/abc.20150093. Epub 2015 Aug 7.
4
Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure.影响心力衰竭患者死亡率和/或心力衰竭住院预测模型预测能力的因素。
JACC Heart Fail. 2014 Oct;2(5):429-36. doi: 10.1016/j.jchf.2014.04.006. Epub 2014 Sep 3.
5
Prediction of heart rate variability on cardiac sudden death in heart failure patients: a systematic review.心力衰竭患者心脏性猝死的心率变异性预测：一项系统评价
Int J Cardiol. 2014 Jul 1;174(3):857-860. doi: 10.1016/j.ijcard.2014.04.176. Epub 2014 Apr 26.
6
Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator.慢性恰加斯病患者与植入式心脏复律除颤器的长期随访
Pacing Clin Electrophysiol. 2014 Jun;37(6):751-6. doi: 10.1111/pace.12342. Epub 2014 Jan 27.
7
Relation of short-term heart rate variability to incident heart failure (from the Multi-Ethnic Study of Atherosclerosis).短期心率变异性与心力衰竭事件的关系（来自动脉粥样硬化多民族研究）。
Am J Cardiol. 2013 Aug 15;112(4):533-40. doi: 10.1016/j.amjcard.2013.04.018. Epub 2013 May 16.
8
A quantitative systematic review of normal values for short-term heart rate variability in healthy adults.健康成年人短期心率变异性正常值的定量系统评价。
Pacing Clin Electrophysiol. 2010 Nov;33(11):1407-17. doi: 10.1111/j.1540-8159.2010.02841.x.
9
Statistical models and patient predictors of readmission for heart failure: a systematic review.心力衰竭再入院的统计模型和患者预测因素：一项系统综述
Arch Intern Med. 2008 Jul 14;168(13):1371-86. doi: 10.1001/archinte.168.13.1371.
10
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator.射血分数小于或等于30%的每个人都应该接受植入式心脏复律除颤器吗？每个射血分数<或 = 30%的人都应该接受植入式心脏复律除颤器。
Circulation. 2005 May 17;111(19):2537-49; discussion 2537-49.
Zotero 插件